A simple pressure pump, made from balloons and nylon stockings, means more people in more places will be able to test water contaminants and blood samples.
The ingenious device unveiled in the prestigious Lab on a Chip journal cost just $2 to make, yet works almost as well as its expensive and cumbersome lab counterparts.
Pumps are used to make biological samples flow through microfluidic devices while their contents are identified beneath a microscope.
This DIY pump came from a collaboration between researchers at RMIT University and the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia, who demonstrated its viability in tests to detect aquatic parasites and cancer cells and to study vascular diseases.
Inspired by football
Study lead author and RMIT engineer, Dr Peter Thurgood,said the team took inspiration for the simple invention from footballs, which hold large pressures when reinforced.
“We started with basic latex balloons, then realised that regular stockings made from nylon and elastane could be a perfect match to reinforce them, allowing them to hold significantly higher pressure and function as pumps,” Thurgood said.
“By simply wrapping three layers of stockings around the latex balloon we were able to increase its internal pressure by a factor of 10 – enough to run many water or blood analyses that would usually require large, expensive pumps.”
Experiments showed the reinforced balloon pump could be used to operate microfluidic devices for several hours without a significant pressure loss.
The pump also fits easily within an incubator and can be left overnight.
A low-cost field tool where it’s needed most
Study co-author and parasitologist at the Walter and Eliza Hall Institute,Associate Professor Aaron Jex, is a leading researcher in global water quality and public health interventions.
He said this simple innovation opened exciting opportunities in field water testing and the ability to test and diagnose patients for infectious pathogens and aquatic micro-organisms at the point-of-care.
“Parasitic micro-organisms have a major impact in impoverished communities in tropical and subtropical regions globally, but also in developed countries including Australia,” Jex said.
“In order to address this there is an urgent need for field-based, low-cost diagnostic tools that work in challenging, sometimes remote and often complex environments very different from a pristine laboratory.”
“As simple as it may look, this device suits those needs really well and could have a big impact.”
Co-author and RMIT biologist, Dr Sara Baratchi, said it also had promising applications for early diagnosis of diseases at home or in the doctor’s surgery.
The balloon pump was tested as a point-of-care diagnostic device for detection of very low concentrations of target cancer cells in liquid samples, and found to work.
“The hydrodynamic force of liquid produced by the reinforced balloon was enough to isolate cells for study, which was really amazing for a $2 pump!”
Baratchi is now working on applying the simplified pump technology to develop organ-on-chip systems that mimic the flow conditions in dysfunctional vessels, to better understand diseases like atherosclerosis that lead to heart attack and stroke.
An opportunity for outreach
RMIT engineer and project leader, Dr Khashayar Khoshmanesh,is a leading researcher in the field of microfluidic based lab-on-a-chip technologies.
He said while microfluidics had made significant progress over the past decade, their widespread application had been limited by the cost and bulk of pumps required to operate them.
“Simplicity is at the heart of our entire research program. By redesigning sophisticated microfluidic devices into simplified ones, we can maximise their outreach and applications for use in teaching or research in the field, not just in sophisticated labs,” he said.
“We envisage these types of pumps also being suitable for student classwork experiments to support capability development in this important area of research from an earlier stage.”
The Latest on: Point-of-care diagnostic device
via Google News
The Latest on: Point-of-care diagnostic device
- Abionic Integrates First Patients in US Clinical Trial for Sepsis Diagnosis Methodon January 10, 2020 at 3:36 am
Abionic SA, Swiss Medtech firm based in Lausanne, is initiating a pivotal clinical trial in the US for an innovative point-of-care diagnostic method for sepsis to validate the results of a first trial ...
- T2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive Officeron January 9, 2020 at 1:22 pm
During 2019, T2 Biosystems achieved a number of important milestones: 1) the T2Resistance™ Panel was granted U.S. Food and Drug Administration Breakthrough Device ... of Chembio Diagnostics, Inc.
- BioDirection®, Inc. Appoints Dr. Jean-Luc Boulnois to its Board of Directorson January 9, 2020 at 6:12 am
"His deep scientific knowledge, understanding of complex medical device development, and leadership experience in bringing high ... to the Board as BioDirection progresses towards its goal of becoming ...
- rHEALTH Technology Granted US Patent for Small Volume Blood Handling in Point-of-Care Deviceson January 9, 2020 at 5:25 am
One of the major bottlenecks in point-of-care diagnostics is the handling of tiny blood samples from a fingerstick ... small blood volume analysis, massive assay multiplexing, and device design. This ...
- Clinical Chemistry Analyzers Market is Poised Expected to Reach a value of ~US$ 16.3 Bn by 2027on January 8, 2020 at 4:02 am
The diagnostic centers segment held a significant share ... Moreover, awareness about various chronic diseases among people is leading to adoption of various point-of-care testing devices, which is ...
- Point-Of-Care Diagnostics Market Scope and Opportunities Analysis 2017 – 2025on January 8, 2020 at 2:16 am
Point-of-care or point-of-use diagnostics, sometimes known as bedside testing, has gained increased prominence in analytical testing over the past few years Global Point-Of-Care Diagnostics Market: ...
- Global In Vitro Diagnostics (IVD) Market Analysis by Product, Technology, Application, End-user, Region and Country - Forecast to 2024on January 8, 2020 at 2:14 am
Dublin, Jan. 08, 2020 (GLOBE NEWSWIRE) -- The "Global In Vitro Diagnostics (IVD) Market: Analysis By Product (Medical Devices, Reagents and Kits, Services), By Technology, Application, End User, By ...
- Point-of-Care Coagulation Testing Devices Market to Undertake Strapping Growth by the End 2027on January 3, 2020 at 2:33 am
Point-of-Care Coagulation Testing Devices Market by Product (Instruments/Analyzers, Consumables and Accessories), Method (PT/INR, Viscoelastic Coagulation Monitoring), End User (Hospitals, Diagnostic ...
- Global Point-Of-Care Diagnostics Market is Projected to Grow at a CAGR of 10.4% from 2019 to 2024on January 2, 2020 at 3:19 am
Dublin, Jan. 02, 2020 (GLOBE NEWSWIRE) -- The "Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, ...
- IIT-M partners with Ricovr for research on medical deviceon December 20, 2019 at 10:04 am
Indian Institute of Technology Madras (IIT-M) has announced that it is going to collaborate with Ricovr Inc. , US-based oral diagnostics medical device company, for research on point-of-care medical ...
via Bing News